Literature DB >> 23744628

Chinese translation and validation of the questionnaire on the process of recovery in schizophrenia and other psychotic disorders.

Wai Tong Chien1, Zenobia C Y Chan.   

Abstract

Individuals recovering from schizophrenia and other psychotic disorders who have residual symptoms can achieve relatively normal work and social functioning in the community. This research aimed to test the psychometric properties of a Chinese version of the 22-item Questionnaire about the Process of Recovery. The translated Chinese QPR had satisfactory semantic equivalence with the original scale and high Cronbach alpha coefficients and test-retest stability at a 2-week interval. When tested in 300 outpatients with psychosis, the Chinese version was found to consist of three factors (Self-Empowerment, Rebuilding Life, and Effective Interpersonal Relationships) with satisfactory correlations with patients' quality of life, self-efficacy, and functioning. The Chinese version appears reliable and valid as a measure of psychotic patients' perceived levels of recovery.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Chinese; psychometric properties; psychotic disorders; recovery; schizophrenia

Mesh:

Year:  2013        PMID: 23744628     DOI: 10.1002/nur.21549

Source DB:  PubMed          Journal:  Res Nurs Health        ISSN: 0160-6891            Impact factor:   2.228


  8 in total

1.  A randomized controlled trial of a mindfulness-based intervention program for people with schizophrenia: 6-month follow-up.

Authors:  Li-Qun Wang; Wai Tong Chien; Lai King Yip; Thanos Karatzias
Journal:  Neuropsychiatr Dis Treat       Date:  2016-12-07       Impact factor: 2.570

2.  An Asian study on clinical and psychological factors associated with personal recovery in people with psychosis.

Authors:  Madeline Lim; Ziqiang Li; Huiting Xie; Bhing Leet Tan; Jimmy Lee
Journal:  BMC Psychiatry       Date:  2019-08-22       Impact factor: 3.630

3.  Increased quality of life in patients with stroke during the COVID-19 pandemic: a matched-pair study.

Authors:  Li Zhao; Xiaoshi Yang; Fengzhi Yang; Guoyuan Sui; Yi Sui; Bing Xu; Bo Qu
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

4.  Mediating effect of empowerment on the relationship between global function and personal recovery among community-dwelling patients with schizophrenia: a cross-sectional study.

Authors:  Kuen Tai Lee; Shih Kai Lee; Mei Jou Lu; Wen Ling Hsieh; Wen I Liu
Journal:  BMC Psychiatry       Date:  2021-05-07       Impact factor: 3.630

5.  Culture-dependent and universal constructs and promoting factors for the process of personal recovery in users of mental health services: qualitative findings from Japan.

Authors:  Akiko Kanehara; Haruna Koike; Yumiko Fujieda; Sayaka Yajima; Asami Kabumoto; Yousuke Kumakura; Kentaro Morita; Yuki Miyamoto; Masahiro Nochi; Kiyoto Kasai
Journal:  BMC Psychiatry       Date:  2022-02-10       Impact factor: 3.630

6.  The Japanese version of the questionnaire about the process of recovery: development and validity and reliability testing.

Authors:  Akiko Kanehara; Risa Kotake; Yuki Miyamoto; Yousuke Kumakura; Kentaro Morita; Tomoko Ishiura; Kimiko Shimizu; Yumiko Fujieda; Shuntaro Ando; Shinsuke Kondo; Kiyoto Kasai
Journal:  BMC Psychiatry       Date:  2017-11-07       Impact factor: 3.630

7.  Measuring mental health recovery: Cross-cultural adaptation of the 15-item Questionnaire about the Process of Recovery in Spain (QPR-15-SP).

Authors:  Jessica Marian Goodman-Casanova; Daniel Cuesta-Lozano; Marta Garcia-Gallardo; Francisco Javier Duran-Jimenez; Fermin Mayoral-Cleries; Jose Guzman-Parra
Journal:  Int J Ment Health Nurs       Date:  2022-03-11       Impact factor: 5.100

8.  Measuring personal recovery in people with bipolar disorder and exploring its relationship with well-being and social role participation.

Authors:  Jannis T Kraiss; Peter M Ten Klooster; Melissa Chrispijn; Anja W M M Stevens; Ralph W Kupka; Ernst T Bohlmeijer
Journal:  Clin Psychol Psychother       Date:  2019-06-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.